At the news
? NEUTRALIMPACT 2/10 144 filed Apr 20, 2026 at 16:43 ET
Atlas Venture Associates XI, L.P., a shareholder of Dyne Therapeutics, filed a Form 144 notifying intent to sell up to 1,401 shares of common stock. The filing is a routine notice of potential sale and does not confirm the transaction has occurred.
- Reporting entity: Atlas Venture Associates XI, L.P.
- Subject company: Dyne Therapeutics, Inc. (DYN)
- Security type: Common stock
- Number of shares proposed for sale: 1,401
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access